PELL BMT (6949) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 沛爾生醫*-創

PELL BMT (6949) reported revenue of NT$2.2 million for Oct 2026, +3.2% year on year and +15.2% from the previous month. Revenue for Jan–Oct 2026 was NT$28.5 million (+4.0% year on year).

Year-on-year revenue growth: 3 months in a row. →

In Oct 2026, it ranked No. 141 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$1.4 million24/10Nov 2024 NT$1.6 millionDec 2024 NT$1.8 millionJan 2025 NT$9.1 millionFeb 2025 NT$1.2 million25/02Mar 2025 NT$1.4 millionApr 2025 NT$1.4 millionMay 2025 NT$2.3 millionJun 2025 NT$2.2 million25/06Jul 2025 NT$3.3 millionAug 2025 NT$2.5 millionSep 2025 NT$1.9 millionOct 2025 NT$2.2 million25/10Nov 2025 NT$1.7 millionDec 2025 NT$2.3 millionJan 2026 NT$2 millionFeb 2026 NT$2 million26/02Mar 2026 NT$2.5 millionApr 2026 NT$3 millionMay 2026 NT$2.7 millionJun 2026 NT$3.3 million26/06Jul 2026 NT$2.5 millionAug 2026 NT$6.5 millionSep 2026 NT$1.9 millionOct 2026 NT$2.2 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$2.2 million+3.2%+15.2%
Sep 2026NT$1.9 million+2.3%-70.3%
Aug 2026NT$6.5 million+164.7%+157.8%
Jul 2026NT$2.5 million-22.6%-23.1%
Jun 2026NT$3.3 million+50.2%+21.7%
May 2026NT$2.7 million+18.8%-9.4%
Apr 2026NT$3 million+107.9%+21.1%
Mar 2026NT$2.5 million+74.5%+24.5%
Feb 2026NT$2 million+61.2%-0.4%
Jan 2026NT$2 million-78.3%-14.6%
Dec 2025NT$2.3 million+26.4%+36.9%
Nov 2025NT$1.7 million+8.0%-21.4%
Oct 2025NT$2.2 million+53.5%+14.1%
Sep 2025NT$1.9 million+8.4%-23.1%
Aug 2025NT$2.5 million+63.4%-24.6%
Jul 2025NT$3.3 million+87.6%+49.4%
Jun 2025NT$2.2 million+58.1%-3.8%
May 2025NT$2.3 million+55.2%+58.5%
Apr 2025NT$1.4 million-34.3%+1.6%
Mar 2025NT$1.4 million-22.5%+15.0%
Feb 2025NT$1.2 million-25.8%-86.6%
Jan 2025NT$9.1 million+495.0%+398.6%
Dec 2024NT$1.8 million+49.5%+17.0%
Nov 2024NT$1.6 million+215.3%+11.7%
Oct 2024NT$1.4 million-15.7%-19.5%

Jan–Oct 2026 cumulative: NT$28.5 million (+4.0% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: PELL BMT vs PEC / PELL BMT vs Lotus Pharm / PELL BMT vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16